BayWa's Creditor War and Criminal Probe: A Race Against the Autumn Deadline

BayWa faces a €2.7bn financing gap, criminal probes into former CEOs, a creditor standoff, and a collapsed €1.7bn renewables sale as restructuring looms.

With a €2.7 billion financing gap still unplugged and a standstill agreement set to expire in autumn 2026, BayWa is waging a battle on two separate fronts. One pits its two main creditor groups against each other in an increasingly bitter power struggle. The other involves criminal investigators and financial regulators circling the Munich-based agricultural conglomerate's past disclosures.

The Legal Front: Raids, Reprimands and Lawsuits

The Munich I public prosecutor's office has opened investigations into former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and incorrect presentation of the 2023 annual financial statements. Raids were carried out at the company's premises in January 2026. Both men maintain their innocence – the presumption of innocence applies.

The probe stems from a formal reprimand by Germany's financial watchdog BaFin, which found that BayWa's 2023 management report omitted crucial details about a billion-euro loan and refinancing risks tied to a €500 million bond. The company has appealed the finding.

The fallout is spreading. The audit oversight body Apas is examining whether auditor PricewaterhouseCoopers was justified in issuing an unqualified audit opinion for 2023. BayWa itself is weighing potential damages claims against PwC and has put the 2026 audit mandate out to tender. Meanwhile, law firm TILP is preparing class-action lawsuits on behalf of shareholders who held BayWa paper between January 2022 and January 2026. The defendants named include BayWa, former board members and PwC.

The Creditor Standoff: Banks vs. Cooperative Shareholders

Behind the legal noise, an equally toxic conflict is unfolding among those who must finance the rescue. DZ Bank and UniCredit (HVB) are turning the screws on Bavaria's network of cooperative Volks- und Raiffeisenbanks, demanding fresh equity injections to stabilise the heavily indebted group. So far, the cooperatives have flatly refused.

Negotiators are now pressing for a so-called trust model – a mechanism designed to pool the interests of the various creditor groups and keep the company operationally viable until the current standstill agreement lapses in autumn 2026. Whether the model can bridge the gap remains an open question: positions on the equity side are hardened.

The Broken Keystone: €1.7bn Sale Collapses

The original restructuring concept rested entirely on the sale of 51% of the renewables subsidiary BayWa r.e., with a projected €1.7 billion in proceeds. That plan has unravelled. The "One Big Beautiful Bill Act" signed by US President Donald Trump slashed federal support for wind and solar projects, rendering the unit unsaleable under current market conditions.

A revised plan is due by mid-2026 and will demand severe sacrifices. Creditors are expected to waive roughly €1 billion in debt. Around 1,300 jobs will be cut, and revenue is to be pared back to €10 billion by 2028.

The Other Key Asset: T&G Global

A further pillar for debt reduction is the planned disposal of the New Zealand subsidiary T&G Global. Goldman Sachs has been mandated since March 2026 to find a buyer for BayWa's 74% stake. A successful deal could fetch around €300 million, but the complicated shareholder structure – Hong Kong's Joy Wing Mau Group holds the remaining 26% and has a right of first refusal – is muddying the process.

Operational Glimmer, Structural Drag

Amid the chaos, the operating business provided a rare bright spot. The first-quarter 2026 adjusted EBITDA surpassed the targets set in the restructuring plan. But weak construction activity and geopolitical tensions continue to weigh heavily on the agriculture and building materials divisions.

Delayed Accounts and Market Jitters

The audited 2025 annual report has been pushed back to the fourth quarter of 2026, with management citing the complexity of impairment assessments and the ongoing recalibration of the restructuring programme. For investors, that means fundamental benchmarks are unavailable for months.

The stock reflects the uncertainty. Trading at €13.00, BayWa shares have lost nearly 24% over the past year and sit roughly 45% below their 52-week high of €23.90 – although they have recovered somewhat from the ten-year trough hit in late May. With a 30-day annualised volatility of more than 100%, the paper is a trader's headache more than a long-term bet.

A court-appointed overhaul of the supervisory board has brought in Dr Ines Kapphan, Solveig Menard-Galli and Christine Rittner-Koch. Their job, like everyone else's, is to steer the company through to autumn – when the truce with the banks either holds or collapses, and the question of BayWa's survival is finally answered.